Medical News
Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1-Negative Advanced NSCLC
New England Journal of Medicine - 25 Oct 2026 09:15
New England Journal of Medicine, Ahead of Print.
Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C-Mutated NSCLC
New England Journal of Medicine - 25 Oct 2026 03:30
New England Journal of Medicine, Ahead of Print.
Osimertinib-Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy
New England Journal of Medicine - 25 Oct 2026 03:30
New England Journal of Medicine, Ahead of Print.